Qiagen N.V. (QIA) - Product Pipeline Analysis

Qiagen N.V. (QIA) - Product Pipeline Analysis

Summary

Qiagen N.V. (Qiagen) is a healthcare company providing sample and assay technologies. Through its sample technologies, the company isolates and processes proteins, DNA and RNA from biological samples such as blood or tissue; and through assay technologies, it develops isolated biomolecules, such as the DNA of a specific virus used for subsequent analysis. The company has over 500 products that include consumable products, automated solutions for sample collection, and nucleic acid and protein handling, separation, and purification, as well as open and target specific assays. Qiagen also supplies diagnostic test kits and assays for human and veterinary molecular diagnostics. The company operates in more than 100 countries and sells its products to pharmaceutical and biotechnology companies and research institutions. Qiagen is headquartered in Venlo, the Netherlands.

Qiagen is keen on enhancing its operations through strategic acquisitions. In line with this strategy, it recently completed the acquisition of AmniSure International LLC and Cellestis Limited.

This report is a source for data, analysis and actionable intelligence on the Qiagen N.V. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize. SHOW LESS READ MORE >

List of Tables
List of Figures
Qiagen N.V. - Business Description
Key Facts
Qiagen N.V. - Major Products and Services
Qiagen N.V. Pipeline Products by Equipment Type
Qiagen N.V. Pipeline Products by Development Stage
Qiagen N.V. Pipeline Products by Therapy Area
Qiagen N.V. Pipeline Products by Trial Phase
Qiagen N.V. Pipeline Products by Milestone Summary
ABL Assay
ABL Assay Product Status
ABL Assay Product Description
ABL Assay Product Patent Details
Artus CT/NG Assay
Artus CT/NG Assay Product Status
Artus CT/NG Assay Product Description
Artus EBV RG 6000 Assay
Artus EBV RG 6000 Assay Product Status
Artus EBV RG 6000 Assay Product Description
Artus EBV RG 6000 Assay Clinical Trial
Artus RG PCR CMV Assay
Artus RG PCR CMV Assay Product Status
Artus RG PCR CMV Assay Product Description
Companion Diagnostic Test - ALK Gene
Companion Diagnostic Test - ALK Gene Product Status
Companion Diagnostic Test - ALK Gene Product Description
Companion Diagnostic Test - IDH1/IDH2 Gene
Companion Diagnostic Test - IDH1/IDH2 Gene Product Status
Companion Diagnostic Test - IDH1/IDH2 Gene Product Description
Diagnostic Test - Latent Tuberculosis
Diagnostic Test - Latent Tuberculosis Product Status
Diagnostic Test - Latent Tuberculosis Product Description
Product Institution Details
EGFR vIII Assay - Glioblastoma
EGFR vIII Assay - Glioblastoma Product Status
EGFR vIII Assay - Glioblastoma Product Description
EGFR vIII Assay - Glioblastoma Clinical Trial
mSept9 Colorectal Cancer Test
mSept9 Colorectal Cancer Test Product Status
mSept9 Colorectal Cancer Test Product Description
NextGen HPV Screening
NextGen HPV Screening Product Status
NextGen HPV Screening Product Description
NextGen HPV Screening Clinical Trial
NextGen HPV Screening Product Patent Details
PI3K Biomarker Test - Breast Cancer
PI3K Biomarker Test - Breast Cancer Product Status
PI3K Biomarker Test - Breast Cancer Product Description
PI3K Biomarker Test - Lung
PI3K Biomarker Test - Lung Product Status
PI3K Biomarker Test - Lung Product Description
QIAensemble
QIAensemble Product Status
QIAensemble Product Description
QIAensemble 3000+ System With HPV And CT/GC
QIAensemble 3000+ System With HPV And CT/GC Product Status
QIAensemble 3000+ System With HPV And CT/GC Product Description
QIAensemble 3000+ System With HPV And CT/GC Product Patent Details
QIAensemble 400 With Screening/Genotyping
QIAensemble 400 With Screening/Genotyping Product Status
QIAensemble 400 With Screening/Genotyping Product Description
QIAensemble JE2000
QIAensemble JE2000 Product Status
QIAensemble JE2000 Product Description
QIAensemble JE800
QIAensemble JE800 Product Status
QIAensemble JE800 Product Description
QIAensemble SP/2000 With Screening And Genotyping
QIAensemble SP/2000 With Screening And Genotyping Product Status
QIAensemble SP/2000 With Screening And Genotyping Product Description
QIAsymphony RGQ - Artus HBV Test
QIAsymphony RGQ - Artus HBV Test Product Status
QIAsymphony RGQ - Artus HBV Test Product Description
QIAsymphony RGQ - Artus HCV Test
QIAsymphony RGQ - Artus HCV Test Product Status
QIAsymphony RGQ - Artus HCV Test Product Description
QIAsymphony RGQ - Artus HHV-6 Test
QIAsymphony RGQ - Artus HHV-6 Test Product Status
QIAsymphony RGQ - Artus HHV-6 Test Product Description
QIAsymphony RGQ - Artus HIV Test
QIAsymphony RGQ - Artus HIV Test Product Status
QIAsymphony RGQ - Artus HIV Test Product Description
QIAsymphony RGQ - Artus JCV Test
QIAsymphony RGQ - Artus JCV Test Product Status
QIAsymphony RGQ - Artus JCV Test Product Description
QIAsymphony RGQ Upgrade - Therascreen BRAF Kit
QIAsymphony RGQ Upgrade - Therascreen BRAF Kit Product Status
QIAsymphony RGQ Upgrade - Therascreen BRAF Kit Product Description
ResPlex II
ResPlex II Product Status
ResPlex II Product Description
ResPlex II Clinical Trial
Rotor-Gene Q - Therascreen BCR-ABL RGQ PCR Kit
Rotor-Gene Q - Therascreen BCR-ABL RGQ PCR Kit Product Status
Rotor-Gene Q - Therascreen BCR-ABL RGQ PCR Kit Product Description
Therascreen BRAF RGQ PCR Kit
Therascreen BRAF RGQ PCR Kit Product Status
Therascreen BRAF RGQ PCR Kit Product Description
Therascreen EGFR Assay - Tomtovok
Therascreen EGFR Assay - Tomtovok Product Status
Therascreen EGFR Assay - Tomtovok Product Description
Therascreen EGFR Assay - Tomtovok Clinical Trial
Therascreen JAK2 Companion Diagnostic Test - Blood Cancer
Therascreen JAK2 Companion Diagnostic Test - Blood Cancer Product Status
Therascreen JAK2 Companion Diagnostic Test - Blood Cancer Product Description
Therascreen JAK2 Companion Diagnostic Test - Blood Cancer Product Milestone
Therascreen KRAS Assay - Dacomitinib
Therascreen KRAS Assay - Dacomitinib Product Status
Therascreen KRAS Assay - Dacomitinib Product Description
Therascreen KRAS RGQ PCR Kit - Panitumumab
Therascreen KRAS RGQ PCR Kit - Panitumumab Product Status
Therascreen KRAS RGQ PCR Kit - Panitumumab Product Description
Therascreen PI3K RGQ PCR Kit
Therascreen PI3K RGQ PCR Kit Product Status
Therascreen PI3K RGQ PCR Kit Product Description
Qiagen N.V. - Key Competitors
Qiagen N.V. - Key Employees
Qiagen N.V. - Key Employee Biographies
Qiagen N.V. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Qiagen N.V., Recent Developments
Jul 24, 2012: Qiagen Reports Revenue Of $307.2m In Q2 2012
Apr 25, 2012: QIAGEN Reports Revenue Of $296.4m In Q1 2012
Mar 15, 2012: QIAGEN Welcomes US Guideline Changes To Recommend HPV Testing As Part Of Cervical Cancer Screening
Jan 31, 2012: Qiagen Reports Revenue Of $1.2 Billion In 2011
Jan 06, 2012: QIAGEN Launches QIAensemble Decapper Sample Preparation Automation System
Nov 28, 2011: QIAGEN Launches Project To Improve Efficiency And Resource Allocation
Nov 02, 2011: Qiagen Reports Revenue Of $288.9m In Q3 2011
Aug 08, 2011: QIAGEN Opens Taiwan Subsidiary To Further Expand Presence In Asia
Jul 25, 2011: Qiagen Reports Net Sales Of $282.2m In Q2 2011
May 06, 2011: QIAGEN Reaches Milestone With 75 Million Deliveries Of HPV Tests, Announces Strategy Update For QIAensemble Program
Appendix
Methodology
About Us
Contact Us
Disclaimer

List of Tables
Qiagen N.V., Key Facts
Qiagen N.V. Key Pipeline Products by Equipment Type
Qiagen N.V. Key Pipeline Products by Therapy Area
Qiagen N.V. Key Pipeline Products by Development Stage
Qiagen N.V. Key Pipeline Products by Trial Phase
Qiagen N.V., Key Facts
Qiagen N.V., Major Products and Services
Qiagen N.V. Number of Pipeline Products by Equipment Type
Qiagen N.V. Pipeline Products by Equipment Type
Qiagen N.V. Number of Pipeline Products by Development Stage
Qiagen N.V. Pipeline Products by Development Stage
Qiagen N.V. Number of Pipeline Products by Therapy Area
Qiagen N.V. Pipeline Products by Therapy Area
Qiagen N.V. Number of Pipeline Products by Trial Phase
Qiagen N.V. Pipeline Products by Trial Phase
Qiagen N.V. Number of Pipeline Products By Milestone Summary
Qiagen N.V. Pipeline Products by Milestone Summary
ABL Assay - Product Status
ABL Assay - Product Description
ABL Assay - Patent Details1
ABL Assay - Patent Details2
Artus CT/NG Assay - Product Status
Artus CT/NG Assay - Product Description
Artus EBV RG 6000 Assay - Product Status
Artus EBV RG 6000 Assay - Product Description
Artus EBV RG 6000 Assay - Validation Of An Epstein-Barr Viral Load Assay Using The QIAGEN Artus EBV Pcr Analyte-Specific Reagent
Artus RG PCR CMV Assay - Product Status
Artus RG PCR CMV Assay - Product Description
Companion Diagnostic Test - ALK Gene - Product Status
Companion Diagnostic Test - ALK Gene - Product Description
Companion Diagnostic Test - IDH1/IDH2 Gene - Product Status
Companion Diagnostic Test - IDH1/IDH2 Gene - Product Description
Diagnostic Test - Latent Tuberculosis - Product Status
Diagnostic Test - Latent Tuberculosis - Product Description
EGFR vIII Assay - Glioblastoma - Product Status
EGFR vIII Assay - Glioblastoma - Product Description
EGFR vIII Assay - Glioblastoma - Targeting EGFR Induced Oxidative Stress by PARP1 Inhibition in Glioblastoma Therapy
mSept9 Colorectal Cancer Test - Product Status
mSept9 Colorectal Cancer Test - Product Description
NextGen HPV Screening - Product Status
NextGen HPV Screening - Product Description
NextGen HPV Screening - The Next-generation Hybrid Capture High-Risk HPV DNA Assay on a Fully Automated Platform
NextGen HPV Screening - Patent Details1
NextGen HPV Screening - Patent Details2
NextGen HPV Screening - Patent Details3
NextGen HPV Screening - Patent Details4
NextGen HPV Screening - Patent Details5
NextGen HPV Screening - Patent Details6
PI3K Biomarker Test - Breast Cancer - Product Status
PI3K Biomarker Test - Breast Cancer - Product Description
PI3K Biomarker Test - Lung - Product Status
PI3K Biomarker Test - Lung - Product Description
QIAensemble - Product Status
QIAensemble - Product Description
QIAensemble 3000+ System With HPV And CT/GC - Product Status
QIAensemble 3000+ System With HPV And CT/GC - Product Description
QIAensemble 3000+ System With HPV And CT/GC - Patent Details1
QIAensemble 3000+ System With HPV And CT/GC - Patent Details2
QIAensemble 3000+ System With HPV And CT/GC - Patent Details3
QIAensemble 3000+ System With HPV And CT/GC - Patent Details4
QIAensemble 3000+ System With HPV And CT/GC - Patent Details5
QIAensemble 3000+ System With HPV And CT/GC - Patent Details6
QIAensemble 400 With Screening/Genotyping - Product Status
QIAensemble 400 With Screening/Genotyping - Product Description
QIAensemble JE2000 - Product Status
QIAensemble JE2000 - Product Description
QIAensemble JE800 - Product Status
QIAensemble JE800 - Product Description
QIAensemble SP/2000 With Screening And Genotyping - Product Status
QIAensemble SP/2000 With Screening And Genotyping - Product Description
QIAsymphony RGQ - Artus HBV Test - Product Status
QIAsymphony RGQ - Artus HBV Test - Product Description
QIAsymphony RGQ - Artus HCV Test - Product Status
QIAsymphony RGQ - Artus HCV Test - Product Description
QIAsymphony RGQ - Artus HHV-6 Test - Product Status
QIAsymphony RGQ - Artus HHV-6 Test - Product Description
QIAsymphony RGQ - Artus HIV Test - Product Status
QIAsymphony RGQ - Artus HIV Test - Product Description
QIAsymphony RGQ - Artus JCV Test - Product Status
QIAsymphony RGQ - Artus JCV Test - Product Description
QIAsymphony RGQ Upgrade - Therascreen BRAF Kit - Product Status
QIAsymphony RGQ Upgrade - Therascreen BRAF Kit - Product Description
ResPlex II - Product Status
ResPlex II - Product Description
ResPlex II - Evaluation Of Commercial Resplex II V2.0, Multicode-Plx, And Xtag Respiratory Viral Panels For The Diagnosis Of Respiratory Viral Infections In Adults
ResPlex II - Differential Detection Of 19 Respiratory Viruses Including The New Influenza A Strain H1N1 2009 With The Resplex II Plus Panel
Rotor-Gene Q - Therascreen BCR-ABL RGQ PCR Kit - Product Status
Rotor-Gene Q - Therascreen BCR-ABL RGQ PCR Kit - Product Description
Therascreen BRAF RGQ PCR Kit - Product Status
Therascreen BRAF RGQ PCR Kit - Product Description
Therascreen EGFR Assay - Tomtovok - Product Status
Therascreen EGFR Assay - Tomtovok - Product Description
Therascreen EGFR Assay - Tomtovok - Efficacy Study Of EGFR PCR Assay For Lung Cancer
Therascreen JAK2 Companion Diagnostic Test - Blood Cancer - Product Status
Therascreen JAK2 Companion Diagnostic Test - Blood Cancer - Product Description
Therascreen JAK2 Companion Diagnostic Test - Blood Cancer - Product Milestone
Therascreen KRAS Assay - Dacomitinib - Product Status
Therascreen KRAS Assay - Dacomitinib - Product Description
Therascreen KRAS RGQ PCR Kit - Panitumumab - Product Status
Therascreen KRAS RGQ PCR Kit - Panitumumab - Product Description
Therascreen PI3K RGQ PCR Kit - Product Status
Therascreen PI3K RGQ PCR Kit - Product Description
Qiagen N.V., Key Employees
Qiagen N.V., Key Employee Biographies
Qiagen N.V., Subsidiaries

List of Figures
Qiagen N.V. Key Pipeline Products by Equipment Type
Qiagen N.V. Pipeline Products by Equipment Type
Qiagen N.V. Pipeline Products by Development Stage
Qiagen N.V. Pipeline Products by Therapy Area
Qiagen N.V. Pipeline Products by Trial Phase
Qiagen N.V. Pipeline Products by Milestone Summary

Hologic, Inc.
Fisher Scientific Corporation
Sigma-Aldrich Corporation
Life Technologies Corporation
Macherey-Nagel GmbH & Co.
Roche Diagnostics Limited
EMD Millipore
Promega Corporation